Goodwin Procter has advised Vidi Capital on its acquisition of the IM86 – Pictavix group. Vidi Capital has completed the acquisition of the IM86 – Pictavix...
Vidi Capital Acquires IM86 – Pictavix Group
Vidi Capital acquires the CIL11 group: a medical imaging player in Occitanie
Goodwin has advised Vidi Capital. Vidi Capital has just finalized the acquisition of the Centre d’Imagerie du Languedoc (CIL11), further strengthening its position among the leaders...